Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Statistics in Medicine
|
June 1, 2017
Modeling event count data in the presence of informative dropout with application to bleeding and transfusion events in myelodysplastic syndrome
Guoqing Diao, Donglin Zeng, Kuolung Hu, et al.
Biometrics
|
May 21, 2019
Semiparametric frailty models for zero-inflated event count data in the presence of informative dropout
Guoqing Diao, Donglin Zeng, Kuolung Hu, et al.
Journal of Biopharmaceutical Statistics
|
November 28, 2017
Improving the power to establish clinical similarity in a Phase 3 efficacy trial by incorporating prior evidence of analytical and pharmacokinetic similarity
Donglin Zeng, Jean Pan, Kuolung Hu, et al.
Statistics in Medicine
|
March 27, 2015
Hypothesis testing for two-stage designs with over or under enrollment
Donglin Zeng, Fei Gao, Kuolung Hu, et al.
Advances in Therapy
|
November 23, 2016
Estimating Long-Term Survival of Adults with Philadelphia Chromosome-Negative Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia Treated with Blinatumomab Using Historical Data
Arie Barlev, Vincent W Lin, Aaron Katz, et al.
Journal of Biopharmaceutical Statistics
|
March 11, 2014
Multivariate recurrent events in the presence of multivariate informative censoring with applications to bleeding and transfusion events in myelodysplastic syndrome
Donglin Zeng, Joseph G Ibrahim, Ming-Hui Chen, et al.
Biometrics
|
October 22, 2019
Bayesian design of biosimilars clinical programs involving multiple therapeutic indications
Matthew A Psioda, Kuolung Hu, Yang Zhang, et al.
Biometrics
|
July 22, 2014
Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome
Ming-Hui Chen, Joseph G Ibrahim, Donglin Zeng, et al.
Diabetes Care
|
October 27, 2005
The effect of ruboxistaurin on nephropathy in type 2 diabetes
Katherine R Tuttle, George L Bakris, Robert D Toto, et al.
Leukemia & Lymphoma
|
August 22, 2012
A randomized controlled trial of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving decitabine
Peter L Greenberg, Guillermo Garcia-Manero, Michael Moore, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Statistics in Medicine
|
June 1, 2017
Modeling event count data in the presence of informative dropout with application to bleeding and transfusion events in myelodysplastic syndrome
Guoqing Diao, Donglin Zeng, Kuolung Hu, et al.
Biometrics
|
May 21, 2019
Semiparametric frailty models for zero-inflated event count data in the presence of informative dropout
Guoqing Diao, Donglin Zeng, Kuolung Hu, et al.
Journal of Biopharmaceutical Statistics
|
November 28, 2017
Improving the power to establish clinical similarity in a Phase 3 efficacy trial by incorporating prior evidence of analytical and pharmacokinetic similarity
Donglin Zeng, Jean Pan, Kuolung Hu, et al.
Statistics in Medicine
|
March 27, 2015
Hypothesis testing for two-stage designs with over or under enrollment
Donglin Zeng, Fei Gao, Kuolung Hu, et al.
Advances in Therapy
|
November 23, 2016
Estimating Long-Term Survival of Adults with Philadelphia Chromosome-Negative Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia Treated with Blinatumomab Using Historical Data
Arie Barlev, Vincent W Lin, Aaron Katz, et al.
Journal of Biopharmaceutical Statistics
|
March 11, 2014
Multivariate recurrent events in the presence of multivariate informative censoring with applications to bleeding and transfusion events in myelodysplastic syndrome
Donglin Zeng, Joseph G Ibrahim, Ming-Hui Chen, et al.
Biometrics
|
October 22, 2019
Bayesian design of biosimilars clinical programs involving multiple therapeutic indications
Matthew A Psioda, Kuolung Hu, Yang Zhang, et al.
Biometrics
|
July 22, 2014
Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome
Ming-Hui Chen, Joseph G Ibrahim, Donglin Zeng, et al.
Diabetes Care
|
October 27, 2005
The effect of ruboxistaurin on nephropathy in type 2 diabetes
Katherine R Tuttle, George L Bakris, Robert D Toto, et al.
Leukemia & Lymphoma
|
August 22, 2012
A randomized controlled trial of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving decitabine
Peter L Greenberg, Guillermo Garcia-Manero, Michael Moore, et al.
Page
of 2